FIELD: medicine.
SUBSTANCE: group of inventions refers to medicine, specifically to ophthalmology, and is intended for the treatment of dry eye syndrome. Ophthalmic composition consists of polysorbate 80, sodium carboxymethylcellulose, glycerol, boric acid, acrylate/C10-30 alkyl acrylate cross-polymer, castor oil, erythritol, levocarnitine, sodium hydroxide and water. Further, said composition may contain a stabilised oxychlor complex. Ophthalmic composition in an effective amount is administered to the human eye to treat, cure, relieve or prevent dry eye syndrome.
EFFECT: use of the group of inventions makes it possible to obtain an ophthalmic composition of a simpler make-up with increased efficacy in reducing dry eye symptoms.
27 cl, 3 tbl, 4 ex
| Title | Year | Author | Number |
|---|---|---|---|
| STABILIZED OPHTHALMIC COMPOSITIONS CONTAINING OMEGA-3-ACIDS | 2015 |
|
RU2697844C2 |
| COMPOSITION FOR EFFECTIVE LIPID DELIVERY TO HUMAN TEAR FILM USING SALT-SENSITIVE EMULSION SYSTEM | 2012 |
|
RU2772357C2 |
| ARTIFICIAL TEARS AND THERAPEUTIC APPLICATION | 2010 |
|
RU2589837C2 |
| ARTIFICIAL TEARS COMPRISING SODIUM HYALURONATE AND CARBOXYMETHYLCELLULOSE | 2014 |
|
RU2687275C2 |
| METHODS AND COMPOSITIONS FOR TREATING DRY EYE DISEASE AND OTHER EYE DISEASES | 2016 |
|
RU2691412C2 |
| ANDROGEN COMPOSITION FOR TREATING OPHTHALMIC CONDITIONS | 2012 |
|
RU2599036C2 |
| OPHTHALMIC COMPOSITION | 2012 |
|
RU2625301C2 |
| COMPOSITIONS PROVIDING INCREASED COMFORT FOR THE EYES | 2018 |
|
RU2806029C2 |
| AQUEOUS PHARMACEUTICAL COMPOSITIONS, CONTAINING BORATE-POLYOL COMPLEXES | 2010 |
|
RU2563125C2 |
| OPHTHALMIC COMPOSITION OF NON-IRRITATING NANOEMULSION CONTAINING CYCLOSPORINE | 2013 |
|
RU2578415C1 |
